Find clinical trials for Asthma in Ann Arbor, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near Ann Arbor, MI, USA:
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Toledo, Ohio, United States and 125 other locations
This is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma...
Phase 3
Ann Arbor, Michigan, United States and 76 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Farmington Hills, Michigan, United States and 43 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Warren, Michigan, United States and 45 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Warren, Michigan, United States and 117 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Ann Arbor, Michigan, United States and 97 other locations
to therapy acting directly on the anti-IL-4R. This will be conducted by examining the effect of a 48 week therapy with dupilumab on the rate of asthma...
Phase 4
Detroit, Michigan, United States and 6 other locations
with TEVA digital inhalers, to develop predictive models for asthma exacerbations and response to biologics using data collected from these ...
Phase 4
Ann Arbor, Michigan, United States
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Windsor, Ontario, Canada and 67 other locations
This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma...
Phase 3
Ypsilanti, Michigan, United States and 141 other locations
Clinical trials
Research sites
Resources
Legal